Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
about
A method for measuring the distribution of the shortest telomeres in cells and tissues.Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cellsOligonucleotides Targeting Telomeres and Telomerase in CancerNOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
P2860
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@en
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@nl
type
label
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@en
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@nl
prefLabel
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@en
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@nl
P2093
P2860
P356
P1433
P1476
Telomerase inhibitor imetelsta ...... omere length dependent manner.
@en
P2093
Adi F Gazdar
Jerry W Shay
Joan H Schiller
John D Minna
Michael Peyton
Robin E Frink
P2860
P304
31639-31651
P356
10.18632/ONCOTARGET.9335
P407
P577
2016-05-12T00:00:00Z